UK's Alliance Pharma agrees to final cash offer from asset management firm DBAY
March 10 (Reuters) - Britain's Alliance Pharma ALAPH.L said on Monday it has agreed to a sweetened final cash proposal from asset management firm DBAY Advisors, valuing the healthcare group at about 362 million pounds ($467.5 million). ($1 = 0.7744 pounds) (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Mrigank Dhaniwala) ((abyjose.koilparambil@thomsonreuters.com;))